Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations

…, MFK Fung, CH Holschneider, LP Parker… - American journal of …, 2011 - Elsevier
Although gynecologic cancers account for only 10% of all new cancer cases in women, these
cancers account for 20% of all female cancer survivors. Improvements in cancer care have …

S ociety of G ynecologic O ncology recommendations for the prevention of ovarian cancer

…, L Chen, J Carter, VL Bae Jump, LP Parker… - Cancer, 2015 - Wiley Online Library
Mortality from ovarian cancer may be dramatically reduced with the implementation of
attainable prevention strategies. The new understanding of the cells of origin and the molecular …

Paget's disease of the vulva: pathology, pattern of involvement, and prognosis

LP Parker, JR Parker, D Bodurka-Bevers… - Gynecologic …, 2000 - Elsevier
Objective.The aim of this study was to determine prognostic factors and risk factors for
recurrence in patients with Paget's disease of the vulva. Methods. The medical records of 76 …

Nodal metastasis risk in endometrioid endometrial cancer

…, JL Walker, DS Metzinger, LP Parker… - Obstetrics & …, 2012 - journals.lww.com
OBJECTIVE: To estimate the risk for nodal metastasis in women with endometrial cancer
based on uterine characteristics on pathology. METHODS: From a study of staging for uterine …

Calciphylaxis with normal renal and parathyroid function: not as rare as previously believed

…, PS Malhotra, JP Callen, LP Parker - Archives of …, 2009 - jamanetwork.com
Background Calciphylaxis is a life-threatening form of metastatic calcification-induced
microvascular occlusion syndrome. Although traditionally observed in patients with end-stage …

RETRACTED: Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer

DD Taylor, C Gercel-Taylor, LP Parker - 2009 - Elsevier
OBJECTIVE: Most ovarian cancers are diagnosed at advanced stage (67%) and prospects
for significant improvement in survival reside in early diagnosis. Our objective was to validate …

Gene expression profiling in response to estradiol and genistein in ovarian cancer cells

LP Parker, DD Taylor, S Kesterson… - Cancer genomics & …, 2009 - cgp.iiarjournals.org
Background: Despite optimal primary treatment of ovarian cancer, overall prognosis is poor
due to recurrences. While steroid hormone receptors are frequently expressed, the role of …

Hyperthermic intraperitoneal chemotherapy in conjunction with surgery for the treatment of recurrent ovarian carcinoma

…, DS Metzinger, ME Gordinier, LP Parker… - Gynecologic …, 2007 - Elsevier
OBJECTIVES.: To review experience of secondary surgical cytoreduction (SSC) with
hyperthermic intraperitoneal chemotherapy (IPHC). METHODS.: Eligible patients with ovarian …

Catumaxomab for the treatment of malignant ascites in patients with chemotherapy-refractory ovarian cancer: a phase II study

JS Berek, RP Edwards, LP Parker… - International Journal of …, 2014 - ijgc.bmj.com
Objective The aim of this study was to investigate the efficacy and safety of intraperitoneal
catumaxomab in heavily pretreated patients with chemotherapy-refractory ovarian cancer and …

Survey of female gynecologic oncologists and fellows: balancing professional and personal life

ME Gordinier, LM Ramondetta, LP Parker, JK Wolf… - Gynecologic …, 2000 - Elsevier
Objective. The aim of this study was to determine how female gynecologic oncologists have
dealt with the challenge of combining childbearing and a career in gynecologic oncology …